Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lowy

Showing results (391-400 of 401) with videos related to

Pageof 41
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2014
Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremiaShari N Gordon, Melvin N Doster, Rhonda C Kines, et al.
NPJ Vaccines|June 8, 2024
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trialJaimie Z Shing, Carolina Porras, Maísa Pinheiro, et al.
Cancer Discovery|November 28, 2019
Gain-of-Function <i>RHOA</i> Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric CancerHaisheng Zhang, Antje Schaefer, Yichen Wang, et al.
The New England Journal of Medicine|December 3, 2025
Noninferiority of One HPV Vaccine Dose to Two DosesAimée R Kreimer, Carolina Porras, Danping Liu, et al.
Vaccine|December 3, 2021
Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trialCarolina Porras, Joshua N Sampson, Rolando Herrero, et al.
Oral Oncology|June 6, 2020
Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCIAimée R Kreimer, Anil K Chaturvedi, Laia Alemany, et al.
Molecular Oncology|December 23, 2023
Strategies to decrease inequalities in cancer therapeutics, care and prevention: Proceedings on a conference organized by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, Vatican City, February 23-24, 2023Ulrik Ringborg, Joachim von Braun, Julio Celis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2023
The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric CancerJoseph A Flores-Toro, Subhashini Jagu, Gregory T Armstrong, et al.
The Lancet. Oncology|June 14, 2015
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA TrialsAimée R Kreimer, Frank Struyf, Maria Rowena Del Rosario-Raymundo, et al.
Science (New York, N.Y.)|March 26, 2016
Basic science: Bedrock of progressFrancis S Collins, James M Anderson, Christopher P Austin, et al.
Pageof 41

Showing results (391-400 of 401) with videos related to

Sort By:
Pageof 41
Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2014
Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremiaShari N Gordon, Melvin N Doster, Rhonda C Kines, et al.
NPJ Vaccines|June 8, 2024
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trialJaimie Z Shing, Carolina Porras, Maísa Pinheiro, et al.
Cancer Discovery|November 28, 2019
Gain-of-Function <i>RHOA</i> Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric CancerHaisheng Zhang, Antje Schaefer, Yichen Wang, et al.
The New England Journal of Medicine|December 3, 2025
Noninferiority of One HPV Vaccine Dose to Two DosesAimée R Kreimer, Carolina Porras, Danping Liu, et al.
Vaccine|December 3, 2021
Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trialCarolina Porras, Joshua N Sampson, Rolando Herrero, et al.
Oral Oncology|June 6, 2020
Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCIAimée R Kreimer, Anil K Chaturvedi, Laia Alemany, et al.
Molecular Oncology|December 23, 2023
Strategies to decrease inequalities in cancer therapeutics, care and prevention: Proceedings on a conference organized by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, Vatican City, February 23-24, 2023Ulrik Ringborg, Joachim von Braun, Julio Celis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2023
The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric CancerJoseph A Flores-Toro, Subhashini Jagu, Gregory T Armstrong, et al.
The Lancet. Oncology|June 14, 2015
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA TrialsAimée R Kreimer, Frank Struyf, Maria Rowena Del Rosario-Raymundo, et al.
Science (New York, N.Y.)|March 26, 2016
Basic science: Bedrock of progressFrancis S Collins, James M Anderson, Christopher P Austin, et al.
Pageof 41